Scott Gottlieb Quotes
The ability of working class Americans to bargain for health coverage at work gave them access to the same basic packages of benefits as executive management teams.
Gottlieb, Scott. "Mad Men and the End of Equal Health Care." Forbes, 2011.
This quotation was reprinted and widely distributed by the CIO in its 1936 organizing drive of the Ford Motor Company
This is one of the classic labor-management problems. It can be solved by legislating minimum wages, having very strong labor unions, that can pressure all the employers of an industry at once, or to have industrial unions as they do in Germany.
At the time, the mine owners and operators claimed that they had NO obligations to their workers—not even to ensure a safe mine. There was no OSHA and workers died and were maimed on the job much more frequently than they do today. Many mine owners now accept that they have obligations to the workers, and the rest are required to have responsible and safe working conditions by law and OSHA regulations.
He had squads of thugs that he would “rent” out to other gangsters for their enforcement activities and to unions to protect themselves from goons and intimidate non union workers. However, he would not let his men work as goons and strike busters or for companies—despite huge pay offers—to keep their workers in line, a common practice at the time.
Scott Gottlieb is an American physician and investor who served as the 23rd commissioner of the Food and Drug Administration (FDA) from 2017 until April 2019. He is presently a resident fellow at the conservative think tank the American Enterprise Institute (AEI), a partner at the venture capital firm New Enterprise Associates (NEA), a member of the board of directors of drug maker Pfizer, Inc, a member of the board of directors of Illumina, Inc., and a contributor to the cable financial news network CNBC. Before becoming FDA commissioner, he was a clinical assistant professor at New York University School of Medicine, the FDA deputy commissioner for medical and scientific affairs, a venture partner with New Enterprise Associates, a member of the policy board of the Leukemia & Lymphoma Society, a senior official at the Centers for Medicare and Medicaid Services, and a member of the Federal Health Information Technology Policy Committee, which advises the United States Department of Health and Human Services on healthcare information technology. He was previously a resident fellow at AEI from 2007 to 2017 prior to joining the FDA as commissioner in May 2017.